YARROW BIOSCIENCE, INC. Stock-Based Compensation
YARROW BIOSCIENCE, INC. (YARW) reported Stock-Based Compensation of $910.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $436.00K, a 17.58% decline year-over-year.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $474.00K, a 37.88% decline year-over-year.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $529.00K, a 40.23% decline year-over-year.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $763.00K, a 22.54% decline year-over-year.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.31M, a 23.09% decline from fiscal 2022.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.30M, a 46.82% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $8.08M, a 55.36% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $18.10M, a 269.77% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $436.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $910.00K 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $474.00K S-4/A · filed 2026-06-03 | |||||||
| 2025-12-31 | $2.31M S-4/A · filed 2026-06-03 | |||||||
| 2025-06-30 | $529.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $1.29M 10-Q · filed 2026-08-13 | $1.99M derived: sum of 3 quarters · filed 2026-08-13 | $2.73M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $763.00K S-4/A · filed 2026-06-03 | $1.46M derived: sum of 2 quarters · filed 2026-06-03 | $2.20M derived: sum of 3 quarters · filed 2026-06-03 | $3.08M derived: sum of 4 quarters · filed 2026-06-03 | ||||
| 2024-12-31 | $699.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | $1.43M derived: sum of 2 quarters · filed 2026-06-03 | $2.32M derived: sum of 3 quarters · filed 2026-06-03 | $3.30M S-4/A · filed 2026-06-03 | ||||
| 2024-09-30 | $734.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.62M derived: sum of 2 quarters · filed 2025-08-14 | $2.60M 10-Q · filed 2024-11-07 | $3.31M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $885.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.87M 10-Q · filed 2025-08-14 | $2.58M derived: sum of 3 quarters · filed 2025-08-14 | $3.44M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $985.00K 10-Q · filed 2025-05-08 | $1.70M derived: sum of 2 quarters · filed 2025-05-08 | $2.56M derived: sum of 3 quarters · filed 2025-05-08 | $3.43M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.57M derived: sum of 2 quarters · filed 2025-03-06 | $2.45M derived: sum of 3 quarters · filed 2025-03-06 | $3.31M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.74M derived: sum of 2 quarters · filed 2024-11-07 | $2.60M 10-Q · filed 2024-11-07 | $3.66M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $876.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.73M 10-Q · filed 2024-08-14 | $2.80M derived: sum of 3 quarters · filed 2024-08-14 | $3.97M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $856.00K 10-Q · filed 2024-05-09 | $1.92M derived: sum of 2 quarters · filed 2024-05-09 | $3.10M derived: sum of 3 quarters · filed 2024-05-09 | $4.26M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $2.24M derived: sum of 2 quarters · filed 2024-03-01 | $3.40M derived: sum of 3 quarters · filed 2024-03-01 | $4.30M 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.34M derived: sum of 2 quarters · filed 2023-11-13 | $3.23M 10-Q · filed 2023-11-13 | $4.56M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.06M 10-Q · filed 2023-08-14 | $3.39M derived: sum of 3 quarters · filed 2023-08-14 | $5.79M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $893.00K 10-Q · filed 2023-05-11 | $2.23M derived: sum of 2 quarters · filed 2023-05-11 | $4.63M derived: sum of 3 quarters · filed 2023-05-11 | $6.53M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $3.74M derived: sum of 2 quarters · filed 2023-03-14 | $5.64M derived: sum of 3 quarters · filed 2023-03-14 | $8.08M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.31M derived: sum of 2 quarters · filed 2022-11-14 | $6.75M 10-Q · filed 2022-11-14 | $9.70M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $4.34M 10-Q · filed 2022-08-12 | $7.30M derived: sum of 3 quarters · filed 2022-08-12 | $9.92M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.44M 10-Q · filed 2022-05-12 | $5.39M derived: sum of 2 quarters · filed 2022-05-12 | $8.02M derived: sum of 3 quarters · filed 2022-05-12 | $18.78M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $5.57M derived: sum of 2 quarters · filed 2022-03-17 | $16.34M derived: sum of 3 quarters · filed 2022-03-17 | $18.10M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $13.39M derived: sum of 2 quarters · filed 2021-11-10 | $15.15M 10-Q · filed 2021-11-10 | $16.44M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $10.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $12.53M 10-Q · filed 2021-08-12 | $13.82M derived: sum of 3 quarters · filed 2021-08-12 | $15.09M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.76M 10-Q · filed 2021-05-06 | $3.05M derived: sum of 2 quarters · filed 2021-05-06 | $4.32M derived: sum of 3 quarters · filed 2021-05-06 | $5.70M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $2.56M derived: sum of 2 quarters · filed 2021-03-04 | $3.94M derived: sum of 3 quarters · filed 2021-03-04 | $4.89M 10-K · filed 2021-03-04 | $6.70M 10-K · filed 2020-03-03 | |||
| 2019-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.66M derived: sum of 2 quarters · filed 2020-11-05 | $3.61M 10-Q · filed 2020-11-05 | $3.56M 10-Q · filed 2019-10-31 | $6.36M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.34M 10-Q · filed 2020-08-06 | $2.09M 10-Q · filed 2019-08-01 | $5.09M derived: sum of 3 quarters · filed 2021-03-04 | $6.09M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-03-31 | $950.00K 10-Q · filed 2020-05-11 | $1.02M 10-Q · filed 2019-05-02 | $3.71M derived: sum of 2 quarters · filed 2021-03-04 | $4.70M derived: sum of 3 quarters · filed 2021-03-04 | $5.45M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2018-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $3.75M derived: sum of 2 quarters · filed 2021-03-04 | $4.50M derived: sum of 3 quarters · filed 2021-03-04 | $5.32M 10-K · filed 2021-03-04 | $3.64M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $995.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.74M derived: sum of 2 quarters · filed 2019-10-31 | $2.56M 10-Q · filed 2019-10-31 | $6.67M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-06-30 | $747.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.57M 10-Q · filed 2019-08-01 | $5.67M derived: sum of 3 quarters · filed 2021-03-04 | $6.26M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-03-31 | $822.00K 10-Q · filed 2019-05-02 | $4.92M derived: sum of 2 quarters · filed 2021-03-04 | $5.51M derived: sum of 3 quarters · filed 2021-03-04 | $5.83M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2017-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $4.69M derived: sum of 2 quarters · filed 2021-03-04 | $5.00M derived: sum of 3 quarters · filed 2021-03-04 | $5.32M 10-K · filed 2021-03-04 | $1.45M 10-K · filed 2018-03-28 | |||
| 2017-09-30 | $589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $901.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.22M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $628.00K 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | $316.00K 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $573.00K 10-K · filed 2019-02-28 | |||||||
| 2015-12-31 | $65.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |